Paper Review Records
全部论文审稿周期
12 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
80
天
196
天
49
天
Impact of Germline DNA Repair Mutations on Clonal Hematopoiesis and Myeloid Neoplasm Development
作者
Kateryna Fedorov; Leo Y. Luo; Alexander G. Bick; Michael R. Savona展开收起
作者单位
1. Vanderbilt-Ingram Cancer Center, Nashville, US; 2. Division of Hematology and Oncology, Department of Medicine, Nashville, US; 3. Vanderbilt School of Medicine, Vanderbilt University Medical Center, Nashville, US; 4. Department of Radiation Oncology, Nashville, US; 5. Division of Genetic Medicine, Department of Medicine, Nashville, US展开收起
48
天
Targeting RUNX1 Germline Variants: Agents Under Investigation
作者
Saman Ghalamkari; Christopher N. Hahn; Amelia Lau; Hamish S. Scott; Claire C. Homan; Anna L. Brown展开收起
作者单位
1. Centre for Cancer Biology, SA Pathology, University of South Australia, Adelaide, Australia; 2. Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia; 3. Adelaide Medical School, The University of Adelaide, Adelaide, Australia展开收起
1
天
The Evolving Therapeutic Landscape of Richter Transformation
作者
Henry Le; Grace Baek; Ivan Huang; Chloe Siu; Mazyar Shadman展开收起
作者单位
1. Department of Pharmacy, Fred Hutchinson Cancer Center, Seattle, USA; 2. Department of Pharmacy, University of Washington Medical Center, Seattle, United States; 3. Department of Cellular Immunotherapy, Fred Hutchinson Cancer Center, Seattle, USA; 4. Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, USA展开收起
17
天
Transforming the Treatment of Acute Lymphoblastic Leukemia: the Role of Bispecific Antibodies, Antibody-Drug Conjugates, and CAR T-cell Therapy
作者
Tala Najdi; Sarah Khanfour; Joe Chalhoub; Shereen Sakkal; Fadi G. Haddad; Hampig Raphael Kourie展开收起
作者单位
1. Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Beirut, Lebanon; 2. Saint Joseph University of Beirut, Beirut, Lebanon; 3. Faculty of Medicine, University of Montreal, Quebec, Canada; 4. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA展开收起
FAQ
Current Hematologic Malignancy Reports审稿要多久?
截至2026-11-19,CrushSCI 收录了 Current Hematologic Malignancy Reports 的 12 篇完整审稿记录。最快一篇从收稿到录用用了 1 天(The Evolving Therapeutic Landscape of Richter Transformation,2025-11-02 收稿,2025-11-03 录用),最慢一篇用了 196 天;平均 57.8 天,中位数 49 天。最快这篇的日期间隔异常短,建议点开原文核对。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
